Clene Inc. (CLNN)
NASDAQ·Healthcare·Biotechnology
$5.90
-2.64%
Mkt Cap $51.08M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$50.00
Range $50.00 – $50.00
Implied Upside
+747.5%
Consensus $50.00 vs current $5.90
NASDAQ·Healthcare·Biotechnology
$5.90
-2.64%
Mkt Cap $51.08M
No recent rating data.
Price Target (1 analysts)
$50.00
Range $50.00 – $50.00
+747.5%
Consensus $50.00 vs current $5.90